These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 8295175)
21. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Khan F; Siddiqui AA Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103 [TBL] [Abstract][Full Text] [Related]
22. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Neidhart M; Wehrli R; Brühlmann P; Michel BA; Gay RE; Gay S Arthritis Rheum; 1999 Apr; 42(4):622-30. PubMed ID: 10211875 [TBL] [Abstract][Full Text] [Related]
23. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis. Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967 [TBL] [Abstract][Full Text] [Related]
24. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis]. Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417 [TBL] [Abstract][Full Text] [Related]
25. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels. Andrés Cerezo L; Kuklová M; Hulejová H; Vernerová Z; Pešáková V; Pecha O; Veigl D; Haluzík M; Pavelka K; Vencovský J; Senolt L Cytokine; 2013 Oct; 64(1):441-7. PubMed ID: 23714112 [TBL] [Abstract][Full Text] [Related]
26. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792 [TBL] [Abstract][Full Text] [Related]
27. Galectin 3 and its binding protein in rheumatoid arthritis. Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084 [TBL] [Abstract][Full Text] [Related]
28. Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis. Furumitsu Y; Inaba M; Yukioka K; Yukioka M; Kumeda Y; Azuma Y; Ohta T; Ochi T; Nishizawa Y; Morii H J Rheumatol; 2000 Jan; 27(1):64-70. PubMed ID: 10648019 [TBL] [Abstract][Full Text] [Related]
29. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367 [TBL] [Abstract][Full Text] [Related]
30. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Galligan CL; Baig E; Bykerk V; Keystone EC; Fish EN Genes Immun; 2007 Sep; 8(6):480-91. PubMed ID: 17568789 [TBL] [Abstract][Full Text] [Related]
31. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis. Shen C; Sun XG; Liu N; Mu Y; Hong CC; Wei W; Zheng F Mol Med Rep; 2015 Feb; 11(2):1528-34. PubMed ID: 25352049 [TBL] [Abstract][Full Text] [Related]
32. Clinical usefulness of basic fibroblast growth factor and E-selectin in patients with rheumatoid arthritis. Sharaki OA; El-Guiziry DA; Abou-Zeid AA; El-Noueam KI; Helal AE; Gaballah AE Egypt J Immunol; 2004; 11(2):91-100. PubMed ID: 16734121 [TBL] [Abstract][Full Text] [Related]
33. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Rousseau JC; Zhu Y; Miossec P; Vignon E; Sandell LJ; Garnero P; Delmas PD Osteoarthritis Cartilage; 2004 Jun; 12(6):440-7. PubMed ID: 15135140 [TBL] [Abstract][Full Text] [Related]
34. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. Emlen W; Niebur J; Flanders G; Rutledge J J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125 [TBL] [Abstract][Full Text] [Related]
35. Lack of a difference in increased capillary blood cell velocity in the skin over proximal interphalangeal joints between rheumatoid arthritis and osteoarthritis. Meyer MF; Czaplewski H; Braun J; Hellmich B; Schatz H; Klein HH Microvasc Res; 2005 Jul; 70(1-2):1-6. PubMed ID: 16098542 [TBL] [Abstract][Full Text] [Related]
36. Increased nitric oxide levels in patients with rheumatoid arthritis. Ueki Y; Miyake S; Tominaga Y; Eguchi K J Rheumatol; 1996 Feb; 23(2):230-6. PubMed ID: 8882024 [TBL] [Abstract][Full Text] [Related]
37. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis. Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512 [TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457 [TBL] [Abstract][Full Text] [Related]
39. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Cerezo LA; Kuklová M; Hulejová H; Vernerová Z; Kaspříková N; Veigl D; Pavelka K; Vencovský J; Šenolt L Mediators Inflamm; 2015; 2015():740357. PubMed ID: 26339140 [TBL] [Abstract][Full Text] [Related]
40. Plasma and synovial fluid programmed cell death 5 (PDCD5) levels are inversely associated with TNF-α and disease activity in patients with rheumatoid arthritis. Wang J; Guan Z; Ge Z Biomarkers; 2013 Mar; 18(2):155-9. PubMed ID: 23327497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]